These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2203928)

  • 1. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
    Feldman RL; Prida XE; Hill JA
    Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA; Allonen H; Arola M; Laaksonen VO
    Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphocreatine in the treatment of patients with myocardial infarct: effects on hemodynamics and oxygen supply].
    Perepech NB; Saks VA; Nedoshivin AO; Kutuzova AE; Alisova NP
    Kardiologiia; 1990 Oct; 30(10):52-5. PubMed ID: 2290272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the combined use of nitrates and beta-adrenergic blockaders on hemodynamics in patients with acute myocardial infarction].
    Gvatua NA; Kravtsov VL; Shumakov VA; Beziuk NN; Galitskaia AK
    Kardiologiia; 1983 Sep; 23(9):29-32. PubMed ID: 6417391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of labetalol on indices of myocardial necrosis in patients with suspected acute infarction.
    Heber ME; Rosenthal E; Thomas N; Haskett VL; Burwood RD; Lutkin J; Vincent R; Chamberlain DA
    Eur Heart J; 1987 Jan; 8(1):11-8. PubMed ID: 3816835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Walker C; Taylor SH
    Int J Cardiol; 1984 Mar; 5(3):317-25. PubMed ID: 6706437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of intravenous labetalol in hypertensive patients with obstructive coronary heart disease complicated by acute myocardial infarction of recent origin.
    Mulac KD; Meryn S
    Eur Heart J; 1983 Jun; 4(6):398-405. PubMed ID: 6617686
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension.
    Immink RV; van den Born BJ; van Montfrans GA; Kim YS; Hollmann MW; van Lieshout JJ
    Hypertension; 2008 Aug; 52(2):236-40. PubMed ID: 18606905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
    Ourbak P; Lardoux H; Pornin M; Bouziri S; Allal J; Duong TC; Sellier P; Maurice M
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1089-96. PubMed ID: 3929738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phentolamine in acute myocardial infarction: hemodynamic and metabolic effects.
    Chatterjee K; Parmley WW
    Acta Med Scand Suppl; 1981; 652():129-34. PubMed ID: 6949459
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of cumulative doses of labetalol in perioperative hypertension.
    Cosentino F; Vidt DG; Orlowski JP; Shiesley D; Little JR
    Cleve Clin J Med; 1989 Jun; 56(4):371-6. PubMed ID: 2743552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD; Bogatyrev IV; Uchaĭkina LV; Syrkin AL
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.